CC BY
1312. Бабажанов А.С. и др. Результаты эффективности применения малоинвазивных методов хирургического лечения острого холецистита у больных пожилого возраста // Science and World, 2013. С. 82.
13. Давлатов С.С. и др. Эффективность миниинвазивных методов хирургического лечения больных с острым деструктивным холециститом // Academy, 2017. № 7. С. 92-94.
14.Давлатов С.С., Аскаров П.А. Результаты лечения больных с желчеистечением после холецистэктомии // Молодой организатор здравоохранения: сб. науч. ст. студентов, 2013. С. 68.
15.Давлатов С.С. Новый метод детоксикации организма в лечении больных гнойным холангитом // Журнал МедиАль, 2013. № 3 (8).
16.Давлатов С.С. Новый метод детоксикации плазмы путем плазмафереза в лечении холемического эндотоксикоза // Бюллетень Северного Государственного медицинского университета, 2013. Т. 1. С. 6-7.
17. Курбаниязов З.Б. и др. Хирургическое лечение больных с синдромом Мириззи // Врач-аспирант, 2012. Т. 51. № 2.1. С. 135-138.
18. Курбаниязов З.Б. и др. Хирургический подход к лечению больных со «свежими» повреждениями магистральных желчных протоков // Академический журнал Западной Сибири, 2013. Т. 9. № 2. С. 14-15.
19. Курбаниязов З.Б. и др. Эффективность использования миниинвазивных методов хирургического лечения больных с острым деструктивным холециститом // Академический журнал Западной Сибири, 2013. Т. 9. № 4. С. 56-57.
20. Назыров Ф.Г. и др. Повреждения магистральных желчных протоков (частота причины повреждений, классификация, диагностика и лечение) // Хирургия Узбекистана, 2011. № 4. С. 66-73.
ROLE OF CHEMOTHERAPY IN PROPHYLAXIS OF THE LIVER ECHINOCOCCOSIS RECURRENCE
1 2 3
Babajanov A.S. , Saydullaev Z.Ya. , Vohidov J.J.
1Babajanov Akhmadjon Sulatanbaevich - PhD, Associate Professor;
2Saydullaev Zayniddin Yakhshiboevich - Assistant; 3Vohidov Jahongir Jamshedovich - Student, DEPARTMENT OF SURGICAL DISEASES, SAMARKAND STATE MEDICAL INSTITUTE, SAMARKAND, REPUBLIC OF UZBEKISTAN
Abstract: in analysis exposed the results of treatment 513 patients, operated in Samarkand State Medical Institution's clinic of surgical department during for the 10 years (2006-2015y.y). The frequency of recurrence of the patients without chemotherapy has formed 9,7%(n=20). Patients after prophylactic chemotherapy recurrences noted only in 3(0,9%) events. The primary operation on cause of the liver echinococcosis without supporting phylactic chemotherapy, held on in condition of the modern high-tech surgical institution, does not guarantee from recidivation of the disease. Keywords: chemotherapy, liver echinococcosis, prophylaxis.
Introduction. Contemporary condition of the liver echinococcosis surgery cannot be recognized as satisfactory, because after primary performed operation a considerable number of reccurent forms resulting in repeated operations is observed [2, 9, 15]. On evidence different authors, frequency recurrence after surgical treatment of echinococcosis in different localization consist about 10% and hesitant within 3-54% [1, 5, 13]. Most of complicated problem represent repeating and multiple recurrence of echinococcosis, in the time which may be lethal outcome
[4, 8, 16]. An analysis of the literature on the problem shows that the need to conduct against relapse chemotherapy in surgical, and to a greater extent, minimally invasive interventions, is not questioned. At the same time, there is no single approach to the tactics of carrying out against relapse chemotherapy. Thus, Bildik N et al. (2007) concluded that anti-relapse therapy should be performed 3 months before surgery, and if alive proto-scolexes are found during the operation, treatment should be continued for 1 month after the operation [3, 7, 12]. Arif SH et al. (2008) conducted a comparative analysis of the development of relapse in various regimens against relapse therapy and concluded that pre- and postoperative therapy with albendazole generally leads to a decrease in the relapse rate [1, 6, 10]. The authors did not note a significant difference in efficacy in prescribing the drug before or after the operation. Rajesh R et al. (2013), referring to WHO recommendations, are being held against relapse therapy by Albendazol for 4 days prior to intervention and continue for a month after it [7, 11]. Other authors believe that against relapse therapy, Albendazole is sufficient only after invasive manipulations on the parasitic cyst.
Materials and Methods. In analysis exposed the results of treatment 513 patients, operated in Samarkand State Medical Institution's clinic of surgical department during for the 10 years (2006-2015y.y). On the occasion of primary the liver echinococcosis were operated 379 (73,9%) sicks. The portion of multifocal echinococcosis are consisted 26,9% (n=102). Repeatedly on the occasion of the liver echinococcosis and organs of abdominal cavities were operated 134 patients: about reccurent-74(55,2%), residual-13(9,7%), disseminated abdominal cavities of echinococcosis-7(5,2%), about implantation of echinococcosis -39(29,1%), about reinfestation of echinococcosis- 1(0,7%). From them 19 patients were operated in our separation, on 379 primary operation frequency of recurrent consisted 5,0%. The rest of 115 patients, which income to repeating treatment, were operated to other surgical centers. All admitting patients were effected a complex of clinical, laboratory and instrumental researching. Among the instrumental methods of researching are administered radiography, USD and KT.
According to sizes of the sac echinococcosis, its number and localization, the growth parasite of echinococcosis, the complication of character, the condition of fibrous capsule, the general condition of patients were applied to different methods of echinococcectomy and to the methods of liquidation leavings of cavity. For intraoperative manipulation of Hydatid sac most safety and available for practical use were 80-100% glycerin, which heated till 70°c temperature. Glycerin is active even for significant dilution, warrants of its most safety, that proved experimentally [4]. It was detected, that hot solution of glycerin causes death 100% protoscolexes during 1±0,2 min, and complete destroy of acephalocysts occurs on the average in 3±0,5 minutes of exposition.
Results and its discussing. From all the groups of operated patients, 207 patients were limited of limited of surgical operation, chemotherapy were not hold (2006-2008 y). And other 306 operated patients were hold chemotherapy in full content (2008-2015). Albendazole was used in dose 10-12 mg/cg/24 hours recommended WHO (1983). Preparations are assigned discontinuous courses (1 month treatment and 15 days-pause). Number of treatments courses in each observing were selected very seriously individually depending on its size, number and the disposition of sac. During a treatment was hold regularly (1 time in 15 days) clinical, laboratory researching checking for condition of the operative area was realized by way dynamic USD and KT each 3 month during 1 observations and each 6 months at the following years. The frequency of recurrence of the patients without chemotherapy has formed 9,7% (n=20). Patients after prophylactic chemotherapy recurrences noted only in 3(0,9%) events. In rest observations (n=303) after holding courses to postoperative chemotherapy at periods of the observation from 1 year till 5 years of the recurrence disease is not noted. It was hold analyses interaction to localizations of recurrence's sac with revenge of the primary defeat beside 23 sick persons with repeated echinococcosis. In this case a localization of recurrence's sac only 26% sick's
has complied with segmentary localization primary sac, that has allowed to exclude absolute dominance in the role fibrous capsule of recurrence's genesis at the current diseases.
Probability of the development of the recidivation, possibly is connected with that, that primary defeat of liver initially could be plural, but development only one parasitical of the sac is connected with its dominance, competitive suppressing growing of the rest sacs.
Conclusion. The primary operation on cause of the liver echinococcosis without supporting phylactic chemotherapy, held on in condition of the modern high-tech surgical institution, does not guarantee from recidivating of the disease. Using antirecidivation to chemotherapies at postoperative period derived benzimidazole carbamates (albendazole) allows to lead minimum frequency of recidivating to the diseases. Reading to uses of curable isolated to chemotherapy by the liver echinococcosis, strictly connected with area of the primary localization parasitic sac, has formed 26,0% from all recidivation of the forms. The big share echinococcosis recidivating of the sac in removed from primary centre segment (56,5%) and even defeat of the other share (17,5%) call in question role of the fiber capsule of the primary sac as the main factor of the relapse of the disease.
References
1. Azamat S. et al. The role of chemotherapy in prophylaxis of the liver echinococcosis recurrence // European science review, 2016. № 5-6.
2. Kasimov S. et al. Haemosorption in Complex Management of Hepatargia // The International Journal of Artificial Organs., 2013. Т. 36. № 8. С. 548.
3. Kasymov S.Z., Davlatov S.S. Hemoperfusion as a method of homeostasis protection in multiple organ failure syndrome //ББК 51.1+ 74.58 K 22, 2013. С. 85.
4. Minaev S. V. et al. Laparoscopic treatment in children with hydatid cyst of the liver // World journal of surgery, 2017. Т. 41. № 12. С. 3218-3223.
5. Shamsiyev A. et al. The role of chemotherapy in prophylaxis of the liver echinococcosis recurrence // European science review, 2016. № 5-6. С. 143-144.
6. Shamsiyev A.M. et al. Development of surgical treatment of echinococcosis of the liver (literature review) // Modern innovation: current areas of research, 2017. С. 45-49.
7. Гаффаров У.Б. и др. Сравнительная оценка способов обработки полости эхинококковой кисты в эксперименте // Детская хирургия, 2008. № 5. С. 48-52.
8. Курбаниязов З.Б. и др. Совершенствование хирургического лечения эхино-коккоза легких // Актуальные вопросы современной пульмонологии. Ма, 2018. С. 107.
9. Рахманов К.Э. и др. Профилактика и медикаментозное лечение эхинококкоза легких // Актуальные вопросы современной пульмонологии. Ма, 2018. С. 142.
10. Стреляева А.В. и др. Лечение эхинококкоза печени взрослых больных, осложненного пециломикозом и ХОБЛ // Хирургическая практика, 2014. № 1. С. 37-42.
11. Стреляева А.В. и др. Лечение эхинококкоза легких, осложненного пециломикозом, у взрослых больных // Хирургическая практика, 2014. № 1. С. 43-50.
12. Шамсиев А.М. и др. Диагностика и хирургическое лечение эхинококкоза у детей //Детская хирургия, 1999. Т. 5. С. 17-20.
13. Шамсиев А.М. Миниинвазивные хирургические вмешательства при эхинококкозе легких у детей // Здравоохр Таджикистана, 2004. Т. 3. С. 37.
14. Шамсиев А.М., Шамсиев Ж.А., Рахманов К.Э. Анализ результатов хирургического лечения эхинококкоза печени // Вюник наукових дослвджень, 2016. № 1.
15. Шамсиев А.М. и др. Балльная оценка в выборе тактики хирургического лечения эхинококкоза печени // Проблемы современной науки и образования, 2017. № 37. С. 75-79.
16. Шамсиев Ж.А. и др. Результаты хирургического лечения эхинококкоза печени // European Science, 2017. №.7. С. 49-54.
